Dave has 30 years of industry experience spanning the disciplines of Drug Metabolism, Project Management, and Quality Management. He joined EMD Serono in the US (a business of Merck KGaA, Darmstadt, Germany) in November 2016 as Head of Clinical Quality Management after spending the prior 23 years at Pfizer. Dave was a member of the Expert Working Group that developed the recently approved addendum to ICH E6.